RAD1
Cell cycle checkpoint protein RAD1
Also known as: HRAD1, RAD1_HUMAN, REC1
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- O60671
- Gene
- RAD1
- Ensembl
- ENSG00000113456
- Chromosome
- 5
- Canonical length
- 282 aa
- Protein class
- Enzymes, Metabolic proteins, Predicted intracellular proteins
- Subcellular location
- Nucleoplasm,Vesicles
OverviewNCBI Gene
This gene encodes a component of a heterotrimeric cell cycle checkpoint complex, known as the 9-1-1 complex, that is activated to stop cell cycle progression in response to DNA damage or incomplete DNA replication. The 9-1-1 complex is recruited by RAD17 to affected sites where it may attract specialized DNA polymerases and other DNA repair effectors. Alternatively spliced transcript variants of this gene have been described. [provided by RefSeq, Jan 2009]
Canonical amino-acid sequenceUniProt
282 residues, UniProt reviewed canonical sequence.
>O60671|RAD1
1 MPLLTQQIQD EDDQYSLVAS LDNVRNLSTI LKAIHFREHA TCFATKNGIK VTVENAKCVQ
61 ANAFIQAGIF QEFKVQEESV TFRINLTVLL DCLSIFGSSP MPGTLTALRM CYQGYGYPLM
121 LFLEEGGVVT VCKINTQEPE ETLDFDFCST NVINKIILQS EGLREAFSEL DMTSEVLQIT
181 MSPDKPYFRL STFGNAGSSH LDYPKDSDLM EAFHCNQTQV NRYKISLLKP STKALVLSCK
241 VSIRTDNRGF LSLQYMIRNE DGQICFVEYY CCPDEEVPES ESLocalizationUniProt · AlphaFold · HPA
Whether an antibody against RAD1 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.26
- Highest tissue expression
- 8.6 nTPM
Expression across tissuesHPA
Tissue
- skeletal muscle: 8.6 nTPM
- tongue: 7.5 nTPM
- heart muscle: 7.4 nTPM
- lymph node: 7.4 nTPM
- retina: 7.3 nTPM
- adrenal gland: 7.1 nTPM
Single-cell type
- oocytes: 120 nCPM
- syncytiotrophoblasts: 103 nCPM
- cytotrophoblasts: 97 nCPM
- migrating cytotrophoblasts: 92 nCPM
- early primary spermatocytes: 74 nCPM
- extravillous trophoblasts: 64 nCPM
Immune cell
- basophil: 7.4 nTPM
- naive CD8 T-cell: 4.9 nTPM
- naive CD4 T-cell: 4.8 nTPM
- eosinophil: 4.7 nTPM
- naive B-cell: 4.7 nTPM
- MAIT T-cell: 4.5 nTPM
Brain region
- choroid plexus: 15 nTPM
- cerebellum: 13 nTPM
- hypothalamus: 13 nTPM
- cerebral cortex: 12 nTPM
- pons: 11 nTPM
- basal ganglia: 11 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.1
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.27
- DepMap mean gene effect
- -0.65
- DepMap dependency class
- common
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 15% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- cellular response to ionizing radiation
- DNA damage checkpoint signaling
- DNA damage response
- DNA repair
- meiotic recombination checkpoint signaling
- substantia nigra development
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
- DNA clamp superfamily
- Cell cycle checkpoint protein, Rad1
- Rad1/Rec1/Rad17
- Repair protein Rad1/Rec1/Rad17
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of RAD1 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads RAD1 as an antibody target. Whether an autoantibody or antibody against RAD1 could matter depends on whether native RAD1 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
RAD1 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label RAD1 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...